Inventor
YUSAKU HORI
Inventor
JP
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07KPeptides27%
PatentTitleYear
12,303,505Tumor-treating pharmaceutical composition202512,083,112Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer202411,547,705Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer202311,369,623Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitor2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to EISAI R&D MAN CO LTD (4)· patent assignee history
2022Patents assigned to PRISM PHARMA CO LTD (1)· patent assignee history
2022–2025Based in JP· patent location history
2023–2024Patents assigned to MERCK SHARP & DOHME LLC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| EISAI R&D MAN CO LTD | 4 | 2022–2025 |
| MERCK SHARP & DOHME LLC | 2 | 2023–2024 |
| PRISM PHARMA CO LTD | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 4 | 2022–2025 |